Topic

New Jersey

A collection of 449 issues

How to Get Mycapssa (Octreotide Oral) Approved by Cigna in New Jersey: Complete Forms & Appeals Guide

Answer Box: Getting Started with Cigna Coverage for Mycapssa in New Jersey Mycapssa (oral octreotide) requires prior authorization from Cigna, processed through Express Scripts specialty pharmacy. The fastest approval path involves: (1) Your endocrinologist submitting electronic PA via CoverMyMeds with baseline IGF-1 labs and specialist documentation, (2) Setting up Accredo
5 min read

Renewing Advate (octocog alfa) Approval with Aetna CVS Health in New Jersey: Complete Timeline and Documentation Guide

Answer Box: Renewing Advate Coverage in New Jersey Aetna CVS Health requires annual prior authorization renewal for Advate (octocog alfa) in New Jersey, submitted 2-4 weeks before expiration via the Availity portal by your hematologist or hemophilia treatment center (HTC). Essential documents include current factor VIII levels, bleeding logs, weight-based
6 min read

The Requirements Checklist to Get Rystiggo (rozanolixizumab-noli) Covered by Cigna in New Jersey

Answer Box: Getting Rystiggo (rozanolixizumab-noli) Covered by Cigna in New Jersey Cigna requires prior authorization for Rystiggo (rozanolixizumab-noli) in New Jersey. You need confirmed AChR or MuSK antibody-positive generalized myasthenia gravis, MGFA Class II-IV symptoms, and documentation of inadequate response to standard therapies. Submit electronically via CoverMyMeds for fastest processing.
6 min read

How to Get Sylvant (Siltuximab) Covered by Aetna CVS Health in New Jersey: Complete PA Guide & Appeals Process

Answer Box: Getting Sylvant (Siltuximab) Covered by Aetna CVS Health in New Jersey Aetna CVS Health requires prior authorization for Sylvant (siltuximab) for idiopathic multicentric Castleman disease (iMCD), with approval typically taking 14-30 days. Submit via CVS Specialty's Oncology Injectable form with HIV-negative/HHV-8-negative lab results, pathology confirming
5 min read

How to Get Epidiolex (Cannabidiol) Covered by UnitedHealthcare in New Jersey: Complete Approval Guide with Forms and Timelines

Answer Box: Getting Epidiolex Covered by UnitedHealthcare in New Jersey Epidiolex (cannabidiol) requires prior authorization from UnitedHealthcare for FDA-approved seizure disorders (Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex). Most plans require documentation of at least two failed antiepileptic drugs and specialist involvement. If denied, New Jersey offers external review
5 min read